# Ascorbic Acid Treatment in CMT1A Trial (AATIC)

> **NCT00271635** · PHASE2 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 13 (actual)

## Conditions studied

- Charcot-Marie-Tooth Disease
- Hereditary Motor and Sensory Neuropathies

## Interventions

- **DRUG:** Placebo
- **DRUG:** ascorbic acid

## Key facts

- **NCT ID:** NCT00271635
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2008-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271635, "Ascorbic Acid Treatment in CMT1A Trial (AATIC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00271635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*